Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Return on Sales (2024 - 2025)

Historic Return on Sales for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to 34.61%.

  • Pyxis Oncology's Return on Sales changed N/A to 34.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 34.61%, marking a year-over-year change of. This contributed to the annual value of 4.79% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Pyxis Oncology reported Return on Sales of 34.61% as of Q3 2025.
  • Pyxis Oncology's Return on Sales' 5-year high stood at 0.25% during Q1 2024, with a 5-year trough of 34.61% in Q3 2025.